Description
In this ERN Rare-Liver webinar, held on 11 April 2023, the Dr Reiberger and Dr Burghart discuss about the evidence of cirrhosis and portal hypertension in Wilson Disease and share their experience as physicians as well as what are the therapeutic aspects such as the impact of chelator-therapy on acute and chronic liver disease progression and portal hypertension targeted therapy.
Targeted Audience
- General practitioners
- Hepatologists
- Oncologists
- Health care professionals
Portal hypertension (CPSH) in Wilson Disease